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Abstract
Tbx1, a T-box transcription factor, and an important gene for velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS) in humans, causes
outflow tract (OFT) heart defects when inactivated in the mouse. Tbx1 is expressed in the second heart field (SHF) and is required in this tissue for
OFT development. To identify Tbx1 regulated genetic pathways in the SHF, we performed gene expression profiling of the caudal pharyngeal
region in Tbx1−/− and wild type embryos. Isl1, a key marker for the SHF, as well as Hod and Nkx2-6, were downregulated in Tbx1−/− mutants,
while genes required for cardiac morphogenesis, such as Raldh2, Gata4, and Tbx5, as well as a subset of muscle contractile genes, signifying
myocardial differentiation, were ectopically expressed. Pan-mesodermal ablation of Tbx1 resulted in similar gene expression changes, suggesting
cell-autonomous roles of Tbx1 in regulating these genes. Opposite expression changes concomitant with SHF-derived cardiac defects occurred in
TBX1 gain-of-function mutants, indicating that appropriate levels of Tbx1 are required for heart development. When taken together, our studies
show that Tbx1 acts upstream in a genetic network that positively regulates SHF cell proliferation and negatively regulates differentiation, cell-
autonomously in the caudal pharyngeal region.
© 2008 Elsevier Inc. All rights reserved.Keywords: Tbx1; Second heart field; VCFS/DGS; Gene expression profilingIntroduction
The development of the cardiac outflow tract (OFT) is
vulnerable to genetic and environmental insults resulting in
morphological defects of the heart. OFT anomalies, including
abnormal alignment or septation, account for 30% of all cases of
congenital heart disease (Kelly and Buckingham, 2002), some
of which co-occur in genetic syndromes. Velo-cardio-facial
syndrome/DiGeorge syndrome (VCFS/DGS) (DiGeorge, 1965;
Shprintzen et al., 1978) is associated with OFT defects due to de
novo hemizygous 1.5–3 million base pair (Mb) 22q11.2
deletions (Morrow et al., 1995; Shaikh et al., 2000). Studies⁎ Corresponding author. Fax: +1 718 430 8778.
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doi:10.1016/j.ydbio.2008.01.037in the mouse have demonstrated that Tbx1, a member of T-box
containing transcription factor family present within the 1.5 Mb
22q11.2 region, is required for OFT development (Jerome and
Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001).
Functional mutations in TBX1 have been found in rare non-
deleted patients with the syndrome as well (Paylor et al., 2006;
Stoller and Epstein, 2005; Yagi et al., 2003).
Tbx1 is expressed in the non-neural crest derived mesoderm
of the caudal pharyngeal region, which is part of the second heart
field (SHF) (Hu et al., 2004; Xu et al., 2004). Unlike the first
heart field (FHF) cells, which differentiate at the cardiac crescent
stage and give rise to the atria and left ventricle of the heart, SHF
cells differentiate later and give rise to the OFT, right ventricle
and part of the atria (reviewed by Buckingham et al., 2005).
Inactivation of Isl1, a LIM homeodomain transcription factor
expressed in the SHF, resulted in failed formation of the OFT,
right ventricle andmost of the atria due to failed proliferation and
migration of this population of cells (Cai et al., 2003). Thus, the
SHF, via Isl1, contributes significantly to heart development.
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Tbx1-expressing cells in the SHF contribute to the OFT and
right ventricle. In Tbx1−/− embryos, although Tbx1-traced cells
are present normally in the SHF, the contribution to the OFT is
lower than in wild type embryos (Xu et al., 2004). Cell
proliferation is also modestly reduced in the SHF of Tbx1−/−
embryos (Xu et al., 2004; Zhang et al., 2006). Tissue-specific
inactivation of Tbx1 in the SHF by Nkx2-5-Cre (Xu et al., 2004)
or Mesp1-Cre (Zhang et al., 2006) resulted in persistent truncus
arteriosus (PTA) and ventricular septal defect (VSD), same as
those in Tbx1−/− embryos.
Two fibroblast growth factor (Fgf) genes expressed in the
SHF, Fgf8 and Fgf10 are hypothesized to act downstream of
Tbx1 in cardiovascular development (Hu et al., 2004; Vitelli
et al., 2002b). Both genes are downregulated in the SHF of
Tbx1−/− mutants, but surprisingly, Fgf10−/− embryos do not
have OFT defects (Marguerie et al., 2006) nor did Tbx1/Fgf8/
Fgf10 triple heterozygous mice (Aggarwal et al., 2006),
indicating that other genes are responsible for these defects.
Recently, Pitx2 was shown to act downstream of Tbx1 in the
early SHF, but Tbx1/Pitx2 double heterozygosity affected only
OFT alignment but not septation, and it occurred with reduced
penetrance (Nowotschin et al., 2006).
It has been difficult to identify genes downstream of Tbx1 in
the SHF. Here, we report a systematic genome-wide search for
genes regulated directly or indirectly by Tbx1 in the caudal
pharyngeal region containing the SHF. Our data show that global
or pan-mesodermal inactivation of Tbx1 disrupts a network of
genes maintaining cell proliferation in the SHF and causes
ectopic expression of known genes required for differentiation,
whereas overexpression causes opposite expression changes of a
subset of these genes. These findings for the first time delineate a
potential molecular network downstream of Tbx1.Materials and methods
Mouse mutants
Generation of Tbx1+/−, BAC transgenic and Tbx1flox/− mice has been
described previously (Arnold et al., 2006; Merscher et al., 2001). T-Cre
transgenic mice (Perantoni et al., 2005) were obtained from Dr. Mark
Lewandoski. A ROSA26 reporter strain (Soriano, 1999) was obtained from
Jackson Laboratories. Tbx1+/− and BAC transgenic mice are congenic in the
FVB genetic background. ROSA26 mice were maintained in the C57BL6
background. All the other strains were maintained in a mixed C57BL6/129
background.
Mouse embryo dissections
Mouse embryos in the FVB background at E8.75, E9.75 and E10.75 were
isolated in cold PBS. Somite pairs were counted to define the stages: 10–12
pairs of somites were defined as E8.75; 23–25 pairs of somites were defined as
E9.75 and 35–37 pairs of somites were defined as E10.75. The caudal
pharyngeal region without the first pharyngeal arch and the neural tube was
dissected and placed in RNAlater RNA stabilization reagent (QIAGEN) at 4 °C.
Total RNA preparation
To obtain enough RNA for the microarray hybridization experiments,
dissected pharyngeal tissue from 5–10 embryos were pooled. The tissue washomogenized in Buffer RLT (QIAGEN). Total RNA was isolated with either
RNeasy Mini Kit (QIAGEN) (for E9.75 and E10.75 tissue) or the RNeasy
Micro Kit (QIAGEN) (for E8.75 tissue) according to the manufacturer's
protocol. Quality and quantity of total RNA was determined using an
Agilent 2100 Bioanalyzer (Agilent) and a ND-1000 Spectrophotometer
(NanoDrop) respectively.
Target preparation
For total RNA isolated from E9.75 or E10.75 tissue, target preparation was
carried out according to Affymetrix's One-Cycle Eukaryotic Target Labeling
Assay. Specifically, using One-Cycle cDNA Synthesis Kit (Affymetrix), 1–5 μg
total RNA was first reverse transcribed to obtain first-strand cDNA and then
second-stranded cDNAwas synthesized in an RNase H-mediated reaction. The
double-stranded cDNA was purified with the Sample Cleanup Module
(Affymetrix) and this served as a template in the subsequent in vitro
transcription (IVT) reaction using the IVT Labeling Kit (Affymetrix). The
resulting biotinylated cRNA targets were then cleaned up and fragmented with
Sample Cleanup Module (Affymetrix).
For the E8.75 tissue, the biotinylated single-strand cDNA targets were
amplified from 20–50 nanograms (ng) starting total RNA using The Ovation
Biotin RNA Amplification and Labeling System (NuGEN).
Microarray processing
A total of 20 μg fragmented, biotin labeled cRNA (for E9.75 or E10.75
tissue) or 2.2 μg cDNA (for E8.75 tissue) from the last step was hybridized
to the GeneChip Test3 array (Affymetrix) to test the quality of the labeled
target. Targets which passed the test were then hybridized to the GeneChip
Mouse Genome 430A 2.0 Arrays (Affymetrix). Hybridization, washing,
staining and scanning was performed in the AECOM Affymetrix Facility
according to the Affymetrix manual.
Data analysis
GeneChip data were analyzed with ArrayAssist Lite (Stratagene). Briefly,
the original Affymetrix GeneChip CEL files generated by the AECOM
Affymetrix Facility were imported into ArrayAssist Lite and a master data table
based on them was created by GC-RMA. Then the data was converted to
logarithmic scale and the significance analysis was performed using two classes,
unpaired t-test with a cut-off of fold change N2 and p-value b0.05.
Quantitative RT-PCR (qRT-PCR)
To obtain enough total RNA and minimize the variability of gene expression
in individual embryos, each sample contained microdissected tissue from two to
five embryos. Total RNA was isolated using the RNeasy Protect Mini Kit
(Qiagen), and used for the first-strand cDNA synthesis with SuperScript First-
Strand Synthesis System for RT-PCR (Invitrogen). The PCR reactions were
performed in the LightCycler apparatus (Roche) using LightCycler-FastStart
DNAMaster SYBR Green I (Roche). All values were normalized to the level of
Gapdh, which was used as an internal control in each sample. For each
experimental group, three to five samples were tested and the average of them
was calculated. Statistical significance between different groups was calculated
by unpaired Student's t-test. Gene-specific primer pairs used for PCR
amplification are listed in Table S4.
In situ hybridization (ISH)
Digoxigenin-labeled RNA probes for Tbx1 (Nowotschin et al., 2006), Tbx5
(Chapman et al., 1996), Gata4, Isl1 (Cai et al., 2003), and Nkx2-5 (Lyons et al.,
1995) were prepared by standard methods (Roche). All the other probes were
amplified by PCR from either mouse genomic DNA or cDNA, using the primers
listed in Table S5. All forward primers contained T3 polymerase priming
sequence and all reverse primers contained T7 polymerase priming sequence.
The PCR product was purified by the PCR Purification Kit (Qiagen), and anti-
sense RNA was in vitro transcribed and labeled with T7 RNA polymerase
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method. Digoxigenin-labeled RNA probes were purified with mini Quick Spin
RNA Columns (Roche). Whole mount in situ hybridization was performed as
previously described (Nowotschin et al., 2006). To generate histological
sections, embryos following whole mount in situ hybridization were dehydrated
through a graded ethanol series (70% EtOH for 5 min, 95% EtOH for 10 min, 2
times 100% EtOH for 5 min, 100% EtOH for 10 min, 2 times Xylene for
15 min), embedded in paraffin wax and sectioned at a thickness of 10 μm in a
microtome.
Histology
Mouse embryos were dissected in PBS (Mediatech) and fixed in 10% neutral
buffered Formalin solution (Sigma) overnight. They were dehydrated through
graded ethanol, embedded in paraffin and sectioned (7–10 μm) using a
microtome.
In silico promoter analysis
The annotated mouse genomic sequences for Raldh2, Hod, and Nkx2-6
were examined for regions conserved among mammalian species (July 2007
Assembly; UCSC Genome Browser http://genome.ucsc.edu/). Most conserved
blocks were located within 10 kb upstream or downstream of exons of the three.
We searched for T-box binding sequences within each of the gene loci. The
consensus sequences were fully conserved in mouse, rat, and human genomic
DNA.Results
Expression profiling of the caudal pharyngeal apparatus in
Tbx1−/− mutants
To identify genes that act downstream of Tbx1 in the SHF, the
caudal pharyngeal region was microdissected at E8.75 (10–12
somites), E9.75 (23–25 somites) and E10.75 (35–37 somites;
see Fig. S1A in the supplementary material), in both wild type
and Tbx1−/− embryos. The three stages, coincident with highest
Tbx1 expression levels, should provide a complete set of Tbx1-
dependent genes. By quantitative measurements, we found the
morphology of caudal pharyngeal region of Tbx1−/− embryos
was grossly normal at E8.75, though morphological defects due
to hypoplasia of the caudal pharyngeal arches were observed at
E9.75 and E10.75 (see Fig. S2 in the supplementary material).
Labeled targets from three independent pools of RNA samples
were hybridized to Affymetrix arrays, containing over 14,000
known mouse genes. With the criteria of fold change N2 and p-
value b0.05, 120, 89, and 113 probe sets were identified for
stages of E8.75, E9.75, and E10.75 respectively (see Tables S1,
S2, S3 in the supplementary material). The candidates included
genes of all classes (Gene Ontology categories, GO; see Fig.
S1B in the supplementary material). This analysis revealed some
notable trends including a decrease in expression of genes
encoding signaling molecules and increase in expression of
genes encoding structural proteins, over time (see Fig. S1B in the
supplementary material). Visible inspection of the gene lists (see
Tables S1, S2, S3 in the supplementary material) revealed a
strikingly large set of genes required for heart development
altered in the mutant embryos, despite the fact that the heart was
removed from the microdissected tissue (see Fig. S1A in the
supplementary material).The number of genes shared by different stages is sum-
marized in a Venn diagram (see Fig. S1C in the supplementary
material). Comparison of the gene lists revealed that some are
shared by E8.75 and E9.75 or E9.75 and E10.75, but only two
genes, Raldh2 (retinaldehyde dehydrogenase type 2, also
named Aldh1a2) and Cpa1 (carboxypeptidase A1) were shared
among all three stages, indicating a highly dynamic gene ex-
pression profile regulated by Tbx1 during pharyngeal develop-
ment. Morphology alterations at E9.75 and E10.75 could also
have accounted for some of the gene expression changes.
Validation of selected candidate genes
Many of the genes found have important functions in cardiac
development, but were not previously linked to the SHF or
Tbx1. Genes with potential direct relevance to the SHF are
listed in Table 1. Some of these genes were chosen for further
validation by qRT-PCR and ISH (Table 1). Three new pools of
wild type and Tbx1−/− embryo tissue were tested for each stage
by qRT-PCR and p-values were calculated. Unlike the
microarray experiments, all the samples for qRT-PCR analysis
were prepared in the same way, making it possible to directly
compare expression levels of candidate genes at all three stages.
In both qRT-PCR and ISH experiments, Nkx2-5 served as a
negative control because of its unchanged expression in the
SHF of Tbx1 null embryos, while Raldh2 served as a positive
control because its ectopic expression in the pharyngeal
apparatus of Tbx1−/− embryos has been reported at later stages
(Guris et al., 2006; Ivins et al., 2005). As a prelude to ISH
studies, the expression pattern of Tbx1 was assessed in detail
and compared with those of selected genes. Co-expression with
Tbx1 in the SHF was a determining factor for further analysis at
multiple stages.
Hod, Isl1, and Nkx2-6 are downregulated in the SHF of
Tbx1−/− embryos
Hod, also named Hop, encodes an unusual homeobox
domain only protein expressed in the linear heart tube and SHF,
required for forming the ventricular myocardium (Chen et al.,
2002; Shin et al., 2002). We found that Hod was downregulated
2.11 fold at E8.75 by microarray analysis (Table 1), and
confirmed by qRT-PCR analysis (Fig. 1A). ISH results from
E8.5, E8.75, and E9.0 showed that Hod is expressed in both the
pharyngeal arch core mesoderm and the SHF in wild type
embryos (Figs. 1B, E, H), overlapping with Tbx1 expression
(Figs. 1D, G). In contrast to the wild type embryos, Hod
expression was not visible by whole mount ISH in Tbx1−/−
embryos at E8.5 (Fig. 1C). At E8.75, Hod expression was only
observed in the pharyngeal arch core mesoderm, especially in
the first arch mesoderm, but not in the SHF in Tbx1−/− embryos
(Fig. 1F). At E9.0, Tbx1−/− embryos only showed Hod
expression in the cranial part of SHF but not in the caudal
part (Fig. 1I). Although there was a clear downregulation at
E8.75, no significant difference in Hod expression between
wild type and Tbx1−/− embryos was observed after E9.75 by
qRT-PCR (Fig. 1A). These results suggest that Tbx1 may be
Table 1
Selected Tbx1-dependent genes with a potential role in the SHF
Gene
symbol
Probe set ID GenBank ID E8.75 E9.75 E10.75
Fold change p-value Fold change p-value Fold change p-value
Transcriptional regulation
Ankrd1 1420992_at AK009959 2.01 0.231 −1.87 0.025 2.81 0.012
Gata4 a, b 1418863_at NM_008092 4.48 0.144 3.53 0.013 5.51 0.001
Gata5 1450126_at BB447551 2.09 0.164 1.59 0.039 3.54 0.002
Gata6 1425463_at BM214048 −1.07 0.778 1.57 0.077 2.30 0.014
1425464_at BM214048 1.38 0.020 1.76 0.003 2.75 0.003
Hod a,b 1428662_a_at AK009007 −2.11 0.000 −1.63 0.015 1.00 0.990
Irx2 1426298_at AF295369 −2.26 0.030 1.10 0.446 −1.05 0.705
Isl1 a,b 1422720_at BQ176915 −2.40 0.001 1.02 0.896 1.07 0.165
Myocd a 1425978_at AF384055 1.01 0.954 1.17 0.674 4.34 0.003
Nkx2-6a,b 1452018_at AF045150 −4.24 0.004 −3.29 0.005 −1.47 0.026
Sox7a 1416564_at NM_011446 2.19 0.009 1.15 0.370 1.80 0.055
T 1419304_at NM_009309 1.47 0.459 2.24 0.029 1.19 0.303
Tbx5a,b 1425695_at AI425735 2.59 0.161 3.50 0.001 3.57 0.001
Tbx18 1449871_at NM_023814 1.84 0.108 3.08 0.045 2.48 0.002
Zfpm2 a 1449314_at NM_011766 4.47 0.103 2.73 0.003 3.54 0.005
Signaling
Bmp6a 1450759_at NM_007556 −1.01 0.952 −2.06 0.006 1.28 0.185
Dkk1 1420360_at NM_010051 −1.52 0.177 −2.10 0.002 −1.46 0.015
Wnt2 1449425_at BC026373 3.33 0.061 5.01 0.001 5.39 0.006
Wnt11 1450772_at NM_009519 1.00 0.650 1.25 0.311 2.25 0.016
Muscle contraction
Actc1 a 1415927_at NM_009608 3.01 0.251 1.60 0.021 2.72 0.007
Actg2 a 1422340_a_at NM_009610 1.16 0.256 1.19 0.206 2.32 0.024
Actn2 1448327_at NM_033268 4.27 0.178 −1.46 0.157 2.97 0.012
Cnn1a 1417917_at NM_009922 1.13 0.686 1.33 0.087 2.13 0.024
Mybpc3 1418551_at NM_008653 2.00 0.308 1.05 0.778 2.29 0.006
Myh6a,b 1448826_at BB481540 3.89 0.271 4.81 0.001 13.53 0.000
Myl4 1422580_at NM_010858 2.36 0.222 1.05 0.858 7.08 0.004
Myl7a 1449071_at NM_022879 1.80 0.256 1.17 0.327 7.23 0.002
Myom1 1420693_at NM_010867 1.42 0.497 −1.58 0.006 3.12 0.013
Tnnc1 1418370_at NM_009393 2.36 0.200 −1.64 0.017 4.13 0.000
Tnni1 1450813_a_at NM_021467 1.34 0.333 1.20 0.212 3.17 0.006
Tnnt2 1424967_x_at L47552 1.87 0.279 1.27 0.162 5.85 0.001
Ttn 1427446_s_at BC025840 2.77 0.322 1.31 0.082 2.45 0.049
Metabolism
Raldh2 a,b 1422789_at NM_009022 2.45 0.035 4.70 0.016 2.11 0.005
Transport
Cmya1 1419220_at NM_011724 1.22 0.724 −2.20 0.003 1.12 0.551
Fold change is the average of three replicates. Negative numbers mean downregulation in Tbx1 null embryos and positive numbers mean upregulation. p-value is
calculated by Student's t-test. The value is presented as 0.000 when it is less than 0.0005.
a Validated by qRT-PCR (pb0.05)
b Validated by ISH.
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pharyngeal development, but not for its maintenance later on.
Isl1 is the key marker for the SHF and is required for OFT
development (Cai et al., 2003). Inactivation of Isl1 results in
major looping and OFT defects with missing segments of the
heart (Cai et al., 2003). Isl1 expression was decreased 2.4 fold
by microarray analysis and 2.08 fold by qRT-PCR in E8.75
Tbx1−/− embryos (Table 1; Fig. 1A). ISH from E8.5 and E9.0
showed downregulation of Isl1 in the caudal part of the SHF of
Tbx1−/− embryos (Figs. 1J–O), suggesting precise spatial andtemporal regulation by Tbx1. There was no change in the
pattern of Isl1 expression in the pharyngeal endoderm in the
same region, which is another domain of co-expression with
Tbx1 (Figs. 1J–O).
The Nkx2-6 gene belongs to the same NK-2 homeobox gene
family as Nkx2-5 and they have overlapping expression patterns
in the pharyngeal endoderm and SHF (Biben et al., 1998;
Nikolova et al., 1997). While Nkx2-5 was not changed, Nkx2-6
was significantly downregulated in Tbx1−/− mutants at all three
stages, with the greatest change at E8.75 (Table 1), confirmed
Fig. 1. Validation of altered expression for selected downregulated genes in the SHF of Tbx1−/− embryos by qRT-PCR and ISH. (A) Developmental time courses of the
expression of Hod, Isl1, Nkx2-6, and Nkx2-5, which were generated from qRT-PCR data. For these and all time-course graphs in other figures: values are means of at
least three samples and normalized by expression levels of wild type samples at E8.75. *p-value b0.05, **p-value b0.01 (calculated by two-tailed unpaired Student's
t-test). Error bars represent standard deviation. Note the significant decreased expression of Hod, Isl1, Nkx2-6 in Tbx1−/− embryos at E8.75, while Nkx2-5 expression
is not changed. (B–I) Reduced Hod expression in the pharyngeal core mesoderm (white arrow) and SHF (black arrow) of Tbx1−/− embryos (C, F, I) compared with
wild type embryos (B, E, H) and its overlap with the Tbx1 expression domain in these regions of wild type embryos (D, G) at E8.5 (B, C), E8.75 (D–F), and E9.0 (G–
I). Panels B–F depict whole mount ISH analysis and panels G–I show sagittal sections cut from whole mount ISH stained embryos. (J–O) Reduced Isl1 expression in
the caudal part (black arrow) but not the cranial part (red arrow) of the SHF in Tbx1−/− embryos (K, M, O) compared with wild type embryos (J, L, N) at E8.5 (J–M)
and E9.0 (N, O). Panels J–M are transverse sections and panels N, O are sagittal sections. Isl1 expression in the pharyngeal pouch endoderm (asterisk) also remains
intact. (P–S) Nkx2-6 expression is absent in the caudal part of the SHF (arrow), while its expression in the pharyngeal pouch endoderm (asterisk) is still present in
Tbx1−/− embryos (Q) compared with wild type embryos (P) at E9.0. In contrast, Nkx2-5 expression has no difference in wild type (R) and Tbx1−/− (S) embryos. All
sections are sagittal. Scale bars: 300 μm in panels B–I; 200 μm in panels J–S.
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showed that Nkx2-6 expression in the SHF was significantly
reduced in Tbx1−/− embryos, while its expression in the
pharyngeal endoderm is unchanged (Figs. 1P, Q, and data notshown), similar to Isl1. Thus, Hod, Isl1, and Nkx2-6 were
downregulated in the caudal SHF of Tbx1−/− embryos at E8.5–
E9.0. As expected, Nkx2-5 expression was not changed in the
SHF (Figs. 1R, S).
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Tbx1−/− embryos
Numerous transcription factors form an interconnected
network to regulate specification and myocardial differentiation
of the heart (reviewed by Bruneau, 2002). Many of the key
genes in this network were ectopically expressed in Tbx1−/−
embryos (Table 1). In particular, three genes important for
myocardial differentiation, Raldh2, Gata4, and Tbx5, showed
increased expression at multiple stages by microarray (Table 1)
and qRT-PCR analysis at E8.75 and later (Fig. 2A). To
determine whether upregulation of these three genes is specific
to the SHF, ISH experiments were performed.
Raldh2 is an enzyme required for the synthesis of retinoic
acid (RA), one of the earliest morphogens needed for the
specification of linear heart tube (reviewed by Xavier-Neto et
al., 2001). Previous studies of Tbx1 mouse mutants showed
ectopic expression of Raldh2 in the pharyngeal mesoderm of
Tbx1−/− embryos after E9.5, but it was not known whether the
upregulation was due to gene activation or morphological
alterations in these later stages (Guris et al., 2006; Ivins et al.,
2005). ISH analysis showed that Raldh2 was expressed in the
caudal part of the SHF at E9.0 in wild type embryos (Figs. 2C,
E). In contrast, Raldh2 expression was expanded cranially at
E9.0 in Tbx1−/− embryos (Figs. 2D, F). Since there was no
detectable morphological difference between wild type and
Tbx1−/− embryos at E9.0 (compare Figs. 2C and D, and also see
Fig. S2 in the supplementary material), this indicates that
ectopic expression of Raldh2 is likely a direct result of the Tbx1
null mutation and not secondary to morphological defects.
Gata4 is one of the earliest transcription factors expressed in
the heart and is needed for activation of many myocardial
differentiation genes (reviewed by Pikkarainen et al., 2004).
There is a low level ofGata4 expression in the SHF of wild type
embryos at E9.0–E9.5 (Fig. 2G and data not shown), while in
Tbx1−/− embryos, ectopic expression was found throughout the
SHF region at E9.0 and more restricted to the cranial part of the
SHF at E9.5 (Fig. 2H and data not shown).
Tbx5 haploinsufficiency is responsible for human Holt–
Oram syndrome (Bruneau et al., 2001). Although Tbx5−/−
mice have atrial and left ventricular defects, the OFT and right
ventricle are normal, indicating that Tbx5 is not required for
the SHF development (Bruneau et al., 2001). ISH experiments
also showed that Tbx5 was expressed very weakly in the SHF
of wild type embryos (Fig. 2I), but was expressed ectopically
in the caudal SHF of Tbx1−/− embryos at E9.0 and E9.5 (Fig.
2J and data not shown), and as for the other genes, in regions
containing Tbx1 expressing cells (Fig. 2B). In contrast,
Hand1, another gene expressed in the heart tube, did not
show any ectopic expression in the SHF of Tbx1−/− embryos
(Figs. 2K, L).
Ectopic expression of myogenic structural genes in the SHF
As the myocardial progenitor cells differentiate to cardiac
muscle, specific muscle structural genes are expressed, such as
myosins, actins, troponins, calponin, actinin and titin (re-viewed by Franco et al., 1998). Since the heart itself was
removed from the dissected tissues used for microarray
analysis, increased expression of a large group of muscle
contractile genes found by microarray in the homozygous null
mutants, especially at E10.75, was unexpected (Table 1). We
tested three of them, Actc1 (alpha cardiac actin), Myh6 (α-
MHC, alpha myosin heavy chain), and Myl7 (Mlc2a, atrial
myosin light chain 2) by qRT-PCR. The results showed
increased expression of Actc1, Myh6, and Myl7 in Tbx1−/−
embryos at the three stages examined, with the greatest
changes detected at E8.75 (Fig. 3A). Differences in the ability
to detect increased expression earlier in development by qRT-
PCR rather than by microarray reflects enhanced sensitivity of
the qRT-PCR approach.
ISH experiments were performed for Myh6 at E9.0 and
increased expression of Myh6 was detected in the SHF of
Tbx1−/− embryos (Fig. 3C). These results demonstrate muscle
differentiation marker genes were ectopically expressed in the
SHF of Tbx1−/− embryos.
Gene expression changes are cell autonomous
Tbx1 is expressed in both pharyngeal endoderm and
mesoderm and both expression domains seem important for
OFT development (Arnold et al., 2006; Zhang et al., 2006).
Thus it is important to determine whether Tbx1 expression in
the SHF plays a cell-autonomous role in regulating above
downstream genes in the SHF. For this question, we ablated
Tbx1 by crossing Tbx1flox/− mice (Arnold et al., 2006) with
pan-mesodermal expressing T-Cre transgenic mice (Perantoni et
al., 2005). Recombination occurred in mesoderm derived
tissues including the SHF but not in the pharyngeal endoderm
(see Fig. S3A in the supplementary material). We then assessed
Tbx1 expression in conditional null mutant embryos at E9.5 (see
Fig. S3C in the supplementary material) and E10.5 (data not
shown) to determine whether it was properly inactivated. We
found that Tbx1 was expressed normally in the pharyngeal
endoderm as expected, and its expression was reduced in the
mesodermal tissues but not eliminated (see Fig. S3C in the
supplementary material), indicating partial ablation. The
embryos had hypoplastic 2nd, 3rd, and 4th pharyngeal arches
(compare Fig. S3B with 3C in the supplementary material).
These morphological defects were less severe than those in
Tbx1−/− and Mesp1-Cre-mediated conditional mutants, which
completely lacked the caudal pharyngeal arches (Liao et al.,
2004; Zhang et al., 2006). However, as in the Tbx1−/− and
Mesp1-Cre conditional mutants, all T-Cre-mediated conditional
mutant embryos died at birth with a PTA and VSD (see Figs.
S3D–G in the supplementary material), indicating that the Tbx1
expression level was below the dosage threshold needed for
normal outflow tract development in the pharyngeal mesoderm.
We examined the expression patterns of Isl1, Nkx2-6,
Raldh2, Tbx5 and Gata4 in the SHF of these embryos at E9.0
or E9.5. As before, we found Isl1 and Nkx2-6 were down-
regulated (Figs. 4A–D), while Raldh2, Tbx5 and Gata4 were
upregulated (Figs. 4E–J). Our data suggests that alteration of
expression of these genes in the SHF is cell autonomous.
Fig. 2. Validation of altered expression for selected upregulated genes in the SHF of Tbx1−/− embryos by qRT-PCR and ISH. (A) Developmental time courses of the
expression of Raldh2,Gata4, and Tbx5, which were generated from qRT-PCR data. Note the significant increased expression of these three genes in Tbx1−/− embryos at
all three stages. (B–F) Sagittal sectioned (C, D) or whole mount ISH (E, F) at E9.0 show expanded expression (arrow) of Raldh2 in the SHF of Tbx1−/− embryos (D, F)
compared with wild type embryos (C, E), which also overlap Tbx1 expression domain in the SHF of wild type embryos (B). Double-headed arrows in E and F indicate
the relative distance between the cranial border of Raldh2 expression and the caudal border of the first arch. (G–L) Sagittal sections from E9.0 whole mount ISH stained
embryos show expression (arrow) of Gata4 (G, H), Tbx5 (I, J) and Hand1 (K, L) in the SHF of Tbx1−/− embryos (H, J, L) compared with wild type embryos (G, I, K).
Note the ectopic expression of Gata4 and Tbx5 but not Hand1 in Tbx1−/− embryos. Scale bars: 200 μm in panels B–F and panels K, L; 150 μm in panels G–J.
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We previously generated bacterial artificial chromosome
(BAC) transgenic mice overexpressing four transgenes includ-
ing TBX1 (Funke et al., 2001; Merscher et al., 2001). These
mice show reduced viability and malformations in the
derivatives of the pharyngeal apparatus with variable expres-
sivity. Most of these defects were rescued by crossing in the
Tbx1 null allele, indicating the important role of Tbx1 dosagein the pharyngeal development (Liao et al., 2004). Occasionally
intracardiac and OFT defects such as VSD (Merscher et al.,
2001), PTA, and a double outlet right ventricle (DORV) (Liao et
al., 2004) were also found in these mice. Here we performed
more detailed histological studies of the transgenic mice at
E17.5 (n=12) than was previously done (Merscher et al., 2001).
The most common heart defect (5 of 12 embryos) was a
thinning of the myocardial wall in the right ventricle, especially
in the region juxtaposed to the interventricular septum (Figs.
Fig. 3. Validation of altered expression for selected muscle structural genes in the SHF of Tbx1−/− embryos by qRT-PCR and ISH. (A) Developmental time courses of
the expression of muscle structural genes Actc1,Myh6, andMyl7, which were generated from qRT-PCR data. Note the significant increased expression of these genes
in Tbx1−/− embryos at all three stages. (B, C) Sagittal sections from E9.0 whole mount ISH stained embryos show increased expression ofMyh6 (arrow) in the SHF of
Tbx1−/− embryos (C) compared with wild type embryos (B). Scale bars: 150 μm.
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present (data not shown). A membranous VSD, typical in
VCFS/DGS, occurred in 3 out of 12 embryos (Figs. 5E, G).
Interestingly, it was always present together with a DORV, but
not necessarily with myocardial hypoplasia (Figs. 5F, H). In
contrast, none of wild type embryos we checked (n=5) had any
of these defects (Figs. 5A, C, D). Since SHF cells contribute to
endothelial and myocardial components of the OFT, right
ventricle and ventricular septum (Verzi et al., 2005), most of
these defects could be due to the abnormal development of the
SHF resulting from increased TBX1 dosage. We postulated that
some of the genes found by microarray analysis may be altered
in the transgenic embryos, and if so, it would further implicate
their function in the SHF.
Opposite gene expression changes in TBX1 gain-of-function
mutants
To determine whether expression levels of the same genes
that were altered in the Tbx1−/− mutant were also changed in the
TBX1 transgenic embryos, qRT-PCR studies were performed.
Unlike Tbx1−/− mice, TBX1 transgenic embryos do not have
morphological changes in the pharyngeal apparatus (Liao et al.,
2004), which makes them an ideal model to validate whether the
expression changes observed in Tbx1−/− embryos are morphol-
ogy-independent. The expression levels of Hod, Isl1, Nkx2-6,
Raldh2, Tbx5,Gata4, Actc1, andMyh6 in the caudal pharyngeal
apparatus of E8.75 TBX1 transgenic embryos were assessed by
qRT-PCR analysis. Among genes that were downregulated in
Tbx1−/− embryos, Nkx2-6 showed significantly increasedexpression in TBX1 transgenic embryos (Fig. 5K), while three
upregulated genes, Raldh2, Tbx5, and Gata4 showed sig-
nificantly decreased expression (Fig. 5K). There was a reduced
area of Raldh2 expression in the SHF which was detected by
ISH in transgenic embryos as compared to wild type embryos
(Figs. 5I, J).
These results suggest that these four genes, Nkx2-6, Raldh2,
Tbx5 and Gata4, are highly sensitive to altered Tbx1 dosage
and some of them may contribute to the SHF-derived defects in
the transgenic mice. On the other hand, reduction of expression
of Tbx5 and Gata4, whose expression is already at low levels,
may not directly cause the OFT defects present in the transgenic
mice. However, these findings support our conclusion that most
gene expression changes are a result of Tbx1 dosage alteration
and not due to morphological differences. We did not find
significant expression changes for the rest of the genes tested in
TBX1 transgenic embryos (data not shown) indicating either
that these genes are not dosage-sensitive, or their expression
changes were not obvious in some transgenic embryos because
the defects caused by increased Tbx1 dosage were milder than
those in the null mutants.
Discussion
Tbx1, the VCFS/DGS gene, is highly expressed in the SHF
during embryonic development and Tbx1−/− embryos have
major OFT defects. In this study, we dissected the caudal
pharyngeal region containing the SHF from wild type and
Tbx1−/− embryos to identify genetic pathways downstream of
Tbx1 required for heart development. We identified a number of
Fig. 4. Partial inactivation of Tbx1 in mesoderm causes the same gene
expression changes as those in Tbx1−/− embryos. Sagittal sectioned (A–D, G–J)
or whole mount (E, F) ISH at E9.0 (A, B, E–H) or E9.5 (C, D, I, J) show the
same expression changes (arrow) in Tbx1flox/−;T-Cre embryos (B, D, F, H, J)
compared with Tbx1flox/+;T-Cre embryos (A, C, E, G, I) for Isl1 (A, B), Nkx2-6
(C, D), Raldh2 (E, F), Tbx5 (G, H), and Gata4 (I, J). Double-headed arrows
indicate the relative distance between the cranial border of Raldh2 expression
and the caudal border of the first arch. Scale bars: 200 μm in panels A, B, E–H;
400 μm in panels C, D, I, J.
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have not been previously linked to the SHF or Tbx1. What was
particularly striking was a downregulation of Isl1, Hod and
Nkx2-6, among others, coupled with ectopic expression of
genes that promote differentiation, including Raldh2, Gata4,
Tbx5, as well as muscle contractile genes in Tbx1−/− mutants.
In addition, the temporal pattern of expression of these genes
indicates that Tbx1 regulates SHF development no later than
E8.75, consistent with results from a study in which Tbx1 was
ablated at different time points in development. It was shown
that OFT defects in Tbx1 mutants occurred at E8.5–E9.5 (Xu et
al., 2005). Recently, Tbx1 was found to function cell
autonomously in the SHF for OFT development (Zhang et al.,
2006). Similar gene expression changes were observed when a
Tbx1 conditional allele was inactivated using a pan-mesodermal
driver of Cre recombinase, T-Cre. In addition, opposite gene
expression changes caused by overexpression of TBX1,
associated with heart malformations support these findings.
Our data for the first time provides a set of genes downstream of
Tbx1 required for the morphogenesis of the cardiac outflow
tract.
Tbx1 regulates the balance between myocardial proliferation
and differentiation in the SHF through Isl1, Hod and Nkx2.6
Although both FHF and SHF cells are derived from a
common pool of mesodermal progenitors in the early embryo,
they obtain different cell fates and contribute to distinct
regions of the heart during later development (Meilhac et al.,
2004). For example, FHF cells start to differentiate into
myocardial cells at the cardiac crescent stage, while SHF cells
maintain an undifferentiated precursor state until they migrate
into the heart (Cai et al., 2003). Therefore, it is important to
maintain a proliferating as well as undifferentiated progenitor
cell pool in the SHF for appropriate OFT development.
Although reduced cell proliferation together with decreased
cell contribution to the OFT has been found in Tbx1−/−
embryos (Xu et al., 2004; Zhang et al., 2006), the molecular
mechanisms have remained elusive. Here we found that Isl1,
Hod and Nkx2.6 are co-expressed with Tbx1 in the SHF and
are downregulated in Tbx1−/− embryos. These three genes,
particularly the SHF marker, Isl1, have key roles in the
development of the SHF. Inactivation of Isl1 results in failed
OFT and right ventricle formation as well as reduced posterior
atrial development (Cai et al., 2003). It is expressed strongly
in SHF precursor cells, required for cell proliferation and is
downregulated when cells differentiate into myoblasts (Cai et
al., 2003). It has been hypothesized that Isl1 may act
upstream of Tbx1, since Tbx1−/− mutants have only OFT
defects (Kelly, 2005). However, it is not unusual for
transcription factors to have important functions at more
than one stage of development, regulated by different
mechanisms. Our data suggests that Tbx1 regulates Isl1
expression levels from E8.5 to E9.0, when the OFT and heart
chambers are forming. Based upon the known function of Isl1
in promoting proliferation and perhaps also suppressing
differentiation, we hypothesize that Tbx1 maintains Isl1
Fig. 5. SHF-derived cardiac defects and opposite gene expression changes in TBX1 gain-of-function mutants. (A–H) SHF-derived defects in E17.5 BAC transgenic
(TG) embryos overexpressing TBX1 shown by transverse sections. Panels A, C, and D are wild type (WT) embryos. Panel B shows the first BAC transgenic embryo
with a thin myocardial wall of the right ventricle (boxed area and magnified in the insets at the top-right of panels A, B). Panels E and F show ventricular septal defect
(vsd) and double outlet right ventricle (dorv) but normal myocardium in the second BAC transgenic embryo. Panels G and H show the third BAC transgenic embryo
with ventricular septal defect (vsd), double outlet right ventricle (dorv), and right-ventricular myocardial hypoplasia (black arrow). (I, J) Whole-mount ISH show
Raldh2-expressing domain is reduced in the SHF of transgenic embryos (J) compared with wild type embryos (I) at E9.5. Double-headed arrows indicate the
relative distance between the cranial border of expression and the caudal border of the first arch. (K) qRT-PCR analysis of expressions of Nkx2-6, Raldh2, Tbx5, and
Gata4 in BAC transgenic embryos at E8.75. Data displayed here is the mean of at least four independent samples and normalized byGapdh expression. *p-value b0.01,
calculated by two-tailed, unpaired Student's t-test. The error bars indicate the standard deviation. Scale bars: 1 mm in panels A–H and F–I; 200 μm in panels I, J.
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model in Fig. 6.
In addition to Isl1, two other genes, Hod and Nkx2-6, co-
expressed with Tbx1 in the SHF, were downregulated in
Tbx1−/− embryos. Hod encodes an unusual homeodomain
protein that functions at multiple stages in heart development.
Some Hod−/− embryos have extremely thin ventricular walls
(Chen et al., 2002; Shin et al., 2002). In addition to a possible
role in promoting proliferation in the SHF, Hod interacts with
serum response factor (SRF) to inhibit differentiation by
preventing SRF-dependent transcription of muscle structural
genes, such as Actc1, which was upregulated in Tbx1−/−
embryos (Chen et al., 2002; Shin et al., 2002). Inactivation of
Tbx1 causes delayed onset of Hod expression in the SHF,
indicating Tbx1 may promote cell proliferation and inhibit
differentiation throughHod (Fig. 6).Hod is a direct downstream
target gene of Nkx2-5 (Chen et al., 2002; Shin et al., 2002). We
found thatNkx2-5 expression was unaltered in Tbx1−/− embryos.
This indicates that Tbx1 regulates Hod independent of its
regulation by Nkx2-5. Of interest, we found another member of
Nk-2 gene family was downregulated in Tbx1−/− embryos.
Nkx2-6 belongs to the same Nk-2 family of homeobox
transcription factors as Nkx2-5. However, unlike Nkx2-5 null
mutants, which have arrested heart formation at the looping
stage (Lyons et al., 1995), homozygous Nkx2-6 mutant miceare viable and normal (Tanaka et al., 2000). Interestingly,
Nkx2-5/Nkx2-6 double-mutants show some severe pharyngeal
and cardiac defects which were not found in any single
mutants, indicating a functional overlap between these two
genes (Tanaka et al., 2001). In addition, the strong conserva-
tion in the homeodomain between Nkx2-5 and Nkx2-6, as
well as expression overlap between them in the SHF also
suggests molecular and functional redundancy. Since Nkx2-5
acts in a genetic pathway upstream of Hod (Chen et al., 2002;
Shin et al., 2002), and more recently Nkx2-1, another Nk-2
gene was also found to directly regulate Hod expression in the
lung (Yin et al., 2006), it is possible that Tbx1 may regulate
Hod through Nkx2-6 in the SHF. This hypothesis is also
supported by the similar expression dynamics and pattern
between Nkx2-6 and Hod in both wild type and Tbx1−/−
embryos revealed by qRT-PCR and ISH analysis. The role of
Nkx2-6 in OFT development is further supported by the
finding that an NKX2-6 mutation associates with a family
with PTA (Heathcote et al., 2005).
Thus, Isl1, Hod and Nkx2-6 are important genes for the
normal development of the OFT, but besides Isl1, they did not
have defined roles in the SHF, especially downstream of Tbx1.
Our data suggests that Tbx1 supports expression of these genes
to maintain the balance between proliferation and differentiation
of progenitor cells in the SHF (Fig. 6).
Fig. 6. Model for the regulation of SHF development by Tbx1 through a genetic
network. Tbx1maintains the balance between proliferation and differentiation in
the SHF by activating Isl1, Nkx2-6, and Hod, while at the same time inhibiting
Raldh2-Gata4/Tbx5-Actc1/Myh6/Myl7 genetic pathway.
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Raldh2 genetic pathway
Raldh2, Tbx5 and Gata4 play essential roles in regulating
myocardial differentiation and patterning of the linear heart
tube. In particular, Raldh2 is expressed in the posterior
mesoderm precursors of the inflow part of the heart tube
(Moss et al., 1998). Localized synthesis of retinoic acid (RA) by
Raldh2 determines atrial cell fates, whereas ventricular cell fates
occur in the absence of Raldh2 expression and RA signaling
(reviewed by Xavier-Neto et al., 2001). Inhibition of endogen-
ous RA synthesis represses expression of atrial-specific markers
and results in an oversized ventricle and aplastic atria.
Conversely, exogenous RA induces atrial-specific gene expres-
sion and produces a heart with hyperplastic atria but missing
ventricles and OFT (Chazaud et al., 1999; Hochgreb et al.,
2003; Xavier-Neto et al., 1999; Yutzey et al., 1994).
The two genes, Tbx5 and Gata4, physically interact to
regulate transcription of downstream genes (Garg et al., 2003).
Both are expressed in a posterior-to-anterior gradient in the
linear heart tube during heart development (Bruneau et al.,
1999; Molkentin et al., 1997) and both act downstream of
Raldh2 (Kostetskii et al., 1999; Liberatore et al., 2000;
Niederreither et al., 2001). In vitro experiments showed that
Gata4 is necessary and sufficient to induce cardiac differentia-
tion marked by a number of myocardial structural genes
including several genes found in this study, Actc1,Myh6,Myl4,
and Tnnc1 (Grepin et al., 1997; Grepin et al., 1995; Ip et al.,
1994; Jiang and Evans, 1996; Molkentin et al., 1994; Sepulveda
et al., 1998; Zeisberg et al., 2005). Similarly, Tbx5 over-
expression in cell lines can also accelerate myocardial
differentiation and induce Myh6 expression (Ching et al.,
2005; Hiroi et al., 2001). The role of Tbx5 in anterior–posterior
(AP) patterning of the heart is further suggested via mouse
models. Tbx5−/− mouse embryos have hypoplastic posterior
heart structures including the left ventricle, atria, and inflow
tract (Bruneau et al., 2001). Furthermore, ectopic overexpres-
sion of Tbx5 in both chick and mice results in loss ofventricular-specific gene expression and retardation of ventri-
cular chamber morphogenesis (Liberatore et al., 2000; Takeuchi
et al., 2003). Our data is consistent with Tbx1 acting to restrict
myocardial differentiation in the SHF through a Raldh2-Tbx5/
Gata4-Myh6/Myl7/Actc1 pathway, which are all ectopically
expressed in the SHF of Tbx1−/− embryos (Fig. 6).
Gene expression changes versus altered morphology
The caudal pharyngeal apparatus fails to develop in Tbx1−/−
embryos due to defects in neural crest migration (Moraes et al.,
2005; Vitelli et al., 2002a). Seemingly, gene expression changes
we found in Tbx1−/− embryos could be caused by morpholo-
gical defects in these embryos. There are several reasons why
we believe that it is not the case. The first and most important is
that Tbx1−/− embryos at E8.75 did not yet have grossly
detectable morphological defects though subtle changes in cell
populations might have occurred. Second, if changes in gene
expression were due to morphological defects in the caudal
pharyngeal region of Tbx1−/− embryos, we would expect to see
a more general profile of genes with expression changes.
However, according to our experimental results, the expression
levels and patterns of many other SHF and myocardial marker
genes such as Nkx2-5, Foxh1, Mef2c, and Hand1 (see Table S6
in the supplementary material) were not changed in Tbx1−/−
embryos, indicating very selective and specific effect. Third,
Tbx1 is co-expressed with these genes in the SHF, indicating
a possible role of Tbx1 in directly regulating transcription of a
subset of these genes. Finally, we found the opposite expression
changes for some of the same genes in BAC transgenic mice
overexpressing TBX1, in the absence of morphological defects
in the caudal pharyngeal apparatus. Thus, we believe that most
of the changes observed at E8.75 and perhaps an important
subset later, result from gene expression changes in the SHF
cells and not due to gross alterations in cell populations.
We also noted some inconsistencies between our microarray
data and a few previous reports about expression changes of
Tbx1-regulated genes. For example, we previously showed that
Pitx2 expression was downregulated while Isl1 expression did
not change in the SHF of E8.0 Tbx1−/− embryos (Nowotschin et
al., 2006). Our microarray analysis found an increased level of
Pitx2 expression at E9.75 (Table S2) which was not confirmed
by qRT-PCR (data not shown). Decreased Isl1 expression at
E8.75 (Table 1) might suggest different responses to Tbx1-
regulation at different developmental stages. Another example
is expression of Foxa2 and Fgf8, which was previously
reported to be downregulated in the SHF of Tbx1 mutant
embryos (Hu et al., 2004). Although none of them was found by
our microarray experiments, qRT-PCR experiments for these
two genes showed significant downregulation as previously
reported (data not shown). This is why we validated all gene
changes of interest by qRT-PCR and ISH studies.
Conclusions
In the model shown in Fig. 6, we hypothesize that Tbx1
maintains the balance between the proliferation and differentia-
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either directly or indirectly, Isl1, Hod and Nkx2-6. A Raldh2-
Tbx5/Gata4 genetic pathway, normally repressed by Tbx1, may
also contribute to the role of Tbx1 in preventing premature
differentiation of the SHF cells. Inactivation of Tbx1 in the
pharyngeal mesoderm causes the abnormal expression of these
genes, which further disrupts the appropriate proliferation-
versus-differentiation balance required for normal contribution
of SHF cells to the OFT myocardium, resulting in OFT defects.
If the changes are cell autonomous, it is possible that some
could be direct downstream transcriptional target genes of
Tbx1. For example, Isl1, Gata4, and Tbx5 contain one or
multiple T-box consensus binding sites in their promoter or
enhancer regions (Cai et al., 2005; Heicklen-Klein and Evans,
2004; Sun et al., 2004). We also examined the DNA sequence
surrounding the first exon of Raldh2 and found a conserved T-
box consensus sequence present (see Fig. S4 in the supple-
mentary material), suggesting that Tbx1 might be able to
regulate Raldh2 expression levels directly.
Interestingly, for most of these genes, their expression
changes more specifically occurred in the caudal/posterior part
of the SHF region, which may be caused by stronger expression
of Tbx1 itself in the caudal pharyngeal region (Fig. 2B).
Another interpretation is that Tbx1may play a role in regulating
AP patterning of the SHF since some of these genes we found
such as Raldh2, Tbx5, and Gata4 have well-known functions in
regulating AP patterning of the heart tube, as we discussed
above. Further detailed analysis will be necessary to address this
question. In addition, characterization of additional genes found
by microarray analysis would likely expand the genetic network
described here. Finally, nucleotide variations in some of these
genes might influence the expressivity of VCFS/DGS, thereby
serving as genetic modifiers.
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